A discovery-phase urine proteomics investigation in type 1 diabetes

Acta Diabetologica

Volumn 49, Issue 6, 2012, Pages 453-464

  Soggiu, A ^a   Piras, C ^b   Bonizzi, L ^a   Hussein, H A ^a   Pisanu, S ^c   Roncada, P ^d  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF SASSARI   (Italy)

^c Porto Conte Ricerche Srl   (Italy)

^d Istituto Sperimentale Italiano Lazzaro Spallanzani   (Italy)

Author keywords

Biomarkers; Diabetic nephropathy; Microalbuminuria; Type 1 diabetes; Urine proteomics

Indexed keywords

ALPHA 1 MICROGLOBULIN; ALPHA 1B GLYCOPROTEIN; ALPHA2 GLYCOPROTEIN; ALPHA2 THIOL PROTEINASE INHIBITOR; APOLIPOPROTEIN A1; APOLIPOPROTEIN E; CD59 ANTIGEN; CYSTEINE PROTEINASE INHIBITOR; GLYCOPROTEIN; HEMOGLOBIN; PROTEOME; RETINOL BINDING PROTEIN 4; UNCLASSIFIED DRUG; ZINC ALPHA2 GLYCOPROTEIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; ENZYME ACTIVITY; ENZYME REGULATION; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MICROALBUMINURIA; MOLECULAR DYNAMICS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN URINE LEVEL; PROTEOMICS; URINALYSIS;

EID: 84875219662     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-012-0407-0     Document Type: Article

References (84)

1. Bluestone JA, Herold K, Eisenbarth G (2010) Genetics, pathogenesis and clinical interventions in type 1 diabetes. Nature 464(7293):1293-1300
2. Daneman D (2006) Type 1 diabetes. Lancet 367(9513):847-858. doi:10.1016/S0140-6736(06)68341-4
3. Colino E, Alvarez MA, Carcavilla A, Alonso M, Ros P, Barrio R (2010) Insulin dose adjustment when changing from multiple daily injections to continuous subcutaneous insulin infusion in the pediatric age group. Acta Diabetol 47(Suppl 1):1-6. doi:10.1007/s00592-009-0103-x
4. Sahin SB, Cetinkalp S, Ozgen AG, Saygili F, Yilmaz C (2010) The importance of anti-insulin antibody in patients with type 1 diabetes mellitus treated with continuous subcutaneous insulin infusion or multiple daily insulin injections therapy. Acta Diabetol 47(4):325-330. doi:10.1007/s00592-010-0221-5
5. Monami M, Lamanna C, Marchionni N, Mannucci E (2010) Continuous subcutaneous insulin infusion versus multiple daily insulin injections in type 1 diabetes: a meta-analysis. Acta Diabetol 47(Suppl 1):77-81. doi:10.1007/s00592-009-0132-5
6. Klupa T, Skupien J, Cyganek K, Katra B, Sieradzki J, Malecki MT (2011) The dual-wave bolus feature in type 1 diabetes adult users of insulin pumps. Acta Diabetol 48(1):11-14. doi:10.1007/s00592-009-0173-9
7. Raman R, Rani PK, Gnanamoorthy P, Sudhir RR, Kumaramanikavel G, Sharma T (2010) Association of obesity with diabetic retinopathy: Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetics Study (SN-DREAMS Report no. 8). Acta Diabetol 47(3):209-215. doi:10.1007/s00592-009-0113-8
8. Tarquini R, Lazzeri C, Pala L, Rotella CM, Gensini GF (2011) The diabetic cardiomyopathy. Acta Diabetol 48(3):173-181. doi: 10.1007/s00592-010-0180-x
9. May O, Arildsen H (2011) Long-term predictive power of simple function tests for cardiovascular autonomic neuropathy in diabetes: a population-based study. Acta Diabetol 48(4):311-316. doi:10.1007/s00592-011-0283-z
10. Chen SJ, Chou P, Lee AF, Lee FL, Hsu WM, Liu JH, Tung TH (2010) Microaneurysm number and distribution in the macula of Chinese type 2 diabetics with early diabetic retinopathy: a population- based study in Kinmen, Taiwan. Acta Diabetol 47(1):35-41. doi:10.1007/s00592-009-0095-6
11. Gianiorio FE, Casu M, Patrone V, Egan CG, Murialdo G (2011) Effect of pioglitazone on cardiac sympathovagal modulation in patients with type 2 diabetes. Acta Diabetol 48(4):283-290. doi: 10.1007/s00592-011-0258-0
12. Greco D,Gambina F,Maggio F (2009) Ophthalmoplegia in diabetes mellitus: a retrospective study. Acta Diabetol 46(1):23-26. doi: 10.1007/s00592-008-0053-8
13. Atkins RC, Zimmet P (2010) Diabetic kidney disease: act now or pay later. Acta Diabetol 47(1):1-4. doi:10.1007/s00592-010-0175-7
14. Rossing P, de Zeeuw D (2011) Need for better diabetes treatment for improved renal outcome. Kidney Int Suppl 120:S28-S32. doi: 10.1038/ki.2010.513
15. Karlberg C, Falk C, Green A, Sjolie AK, Grauslund J (2011) Proliferative retinopathy predicts nephropathy: a 25-year follow-up study of type 1 diabetic patients. Acta Diabetol. doi:10.1007/s00592-011-0304-y
16. Guo L, Cheng Y, Wang X, Pan Q, Li H, Zhang L, Wang Y (2010) Association between microalbuminuria and cardiovascular disease in type 2 diabetes mellitus of the Beijing Han nationality. Acta Diabetol. doi:10.1007/s00592-010-0205-5
17. Millioni R, Iori E, Puricelli L, Arrigoni G, Vedovato M, Trevisan R, James P, Tiengo A, Tessari P (2008) Abnormal cytoskeletal protein expression in cultured skin fibroblasts from type 1 diabetes mellitus patients with nephropathy: a proteomic approach. Proteomics Clin Appl 2(4):492-503
18. Pan HZ, Zhang L, Guo MY, Sui H, Li H, Wu WH, Qu NQ, Liang MH, Chang D (2010) The oxidative stress status in diabetes mellitus and diabetic nephropathy. Acta Diabetol 47(Suppl 1):71-76. doi:10.1007/s00592-009-0128-1
19. Jia L, Zhang L, Shao C, Song E, Sun W, Li M, Gao Y (2009) An attempt to understand kidney's protein handling function by comparing plasma and urine proteomes. PLoS ONE 4(4):e5146
20. Rao PV, Lu X, Standley M, Pattee P, Neelima G, Girisesh G, Dakshinamurthy K, Roberts CT Jr, Nagalla SR (2007) Proteomic identification of urinary biomarkers of diabetic nephropathy. Diabetes Care 30(3):629-637
21. Thongboonkerd V, Klein J, Jevans A, McLeish K (2004) Urinary proteomics and biomarker discovery for glomerular diseases. Contrib Nephrol 141:292-307
22. Thongboonkerd V (2004) Proteomics in nephrology: current status and future directions. Am J Nephrol 24(3):360-378
23. Thongboonkerd V (2005) Proteomic analysis of renal diseases: unraveling the pathophysiology and biomarker discovery. Expert Rev Proteomics 2(3):349-366
24. Thongboonkerd V, Malasit P (2005) Renal and urinary proteomics: current applications and challenges. Proteomics 5(4):1033-1042
25. Moon PG, You S, Lee JE, Hwang D, Baek MC (2011) Urinary exosomes and proteomics. Mass Spectrom Rev 30(6):1185-1202. doi:10.1002/mas.20319
26. Papale M, Di Paolo S, Magistroni R, Lamacchia O, Di Palma AM, De Mattia A, Rocchetti MT, Furci L, Pasquali S, De Cosmo S, Cignarelli M, Gesualdo L (2010) Urine proteome analysis may allow noninvasive differential diagnosis of diabetic nephropathy. Diabetes Care 33(11):2409-2415. doi:10.2337/dc10-0345
27. Bellei E, Rossi E, Lucchi L, Uggeri S, Albertazzi A, Tomasi A, Iannone A (2008) Proteomic analysis of early urinary biomarkers of renal changes in type 2 diabetic patients. Proteomics Clin Appl 2(4):478-491. doi:10.1002/prca. 200780109
28. Candiano G, Santucci L, Petretto A, Bruschi M, Dimuccio V, Urbani A, Bagnasco S, Ghiggeri GM (2010) 2D-electrophoresis and the urine proteome map: where do we stand? J Proteomics 73(5):829-844. doi:10.1016/j.jprot.2009.12.003
29. Konvalinka A, Scholey JW, Diamandis EP (2012) Searching for new biomarkers of renal diseases through proteomics. Clin Chem 58(2):353-365. doi:10.1373/clinchem.2011.165969
30. Zurbig P, Dihazi H, Metzger J, Thongboonkerd V, Vlahou A (2011) Urine proteomics in kidney and urogenital diseases: Moving towards clinical applications. Proteomics Clin Appl 5(5-6):256-268. doi:10.1002/prca.201000133
31. Decramer S, Gonzalez de Peredo A, Breuil B, Mischak H, Monsarrat B, Bascands JL, Schanstra JP (2008) Urine in clinical proteomics. Mol Cell Proteomics 7(10):1850-1862. doi:10.1074/mcp.R800001-MCP200
32. Merchant ML, Klein JB (2007) Proteomics and diabetic nephropathy. Elsevier, Amsterdam, pp 627-636
33. Torffvit O, Agardh CD (1993) Tubular secretion of Tamm- Horsfall protein is decreased in type 1 (insulin-dependent) diabetic patients with diabetic nephropathy. Nephron 65(2):227-231
34. Torffvit O, Agardh CD (1994) Urinary excretion rate of NC1 and Tamm-Horsfall protein in the microalbuminuric type I diabetic patient. J Diabetes Complicat 8(2):77-83
35. Schlatzer D, Maahs DM, Chance MR, Dazard JE, Li X, Hazlett F, Rewers M, Snell-Bergeon JK (2012) Novel urinary protein biomarkers predicting the development of microalbuminuria and renal function decline in type 1 diabetes. Diabetes Care. doi: 10.2337/dc11-1491
36. Holmquist P, Torffvit O (2008) Tubular function in diabetic children assessed by Tamm-Horsfall protein and glutathione S-transferase. Pediatr Nephrol 23(7):1079-1083. doi:10.1007/s00467-008-0770-9
37. Torffvit O, Jørgensen P, Kamper AL, Holstein-Rathlou NH, Leyssac P, Poulsen S, Strandgaard S (2000) Urinary excretion of Tamm-Horsfall protein and epidermal growth factor in chronic nephropathy. Nephron 79(2):167-172
38. Qin X, Goldfine A, Krumrei N, Grubissich L, Acosta J, Chorev M, Hays AP, Halperin JA (2004) Glycation inactivation of the complement regulatory protein CD59: a possible role in the pathogenesis of the vascular complications of human diabetes. Diabetes 53(10):2653-2661
39. Acosta J, Hettinga J, Flückiger R, Krumrei N, Goldfine A, Angarita L, Halperin J (2000) Molecular basis for a link between complement and the vascular complications of diabetes. Proc Nat Acad Sci 97(10):5450
40. Zhang J, Gerhardinger C, Lorenzi M (2002) Early complement activation and decreased levels of glycosylphosphatidylinositolanchored complement inhibitors in human and experimental diabetic retinopathy. Diabetes 51(12):3499-3504
41. Accardo-Palumbo A, Triolo G, Colonna-Romano G, Potestio M, Carbone M, Ferrante A, Giardina E, Caimi G (2000) Glucoseinduced loss of glycosyl-phosphatidylinositol-anchored membrane regulators of complement activation (CD59, CD55) by in vitro cultured human umbilical vein endothelial cells. Diabetologia 43(8):1039-1047. doi:10.1007/s001250051487
42. Ma XW, Chang ZW, Qin MZ, Sun Y, Huang HL, He Y (2009) Decreased expression of complement regulatory proteins, CD55 and CD59, on peripheral blood leucocytes in patients with type 2 diabetes and macrovascular diseases. Chin Med J 122(18):2123-2128
43. Taskinen MR, Kahri J, Koivisto V, Shepherd J, Packard CJ (1992) Metabolism of HDL apolipoprotein A-I and A-II in type 1 (insulindependent) diabetes mellitus. Diabetologia 35(4):347-356
44. Chen G, Paka L, Kako Y, Singhal P, Duan W, Pillarisetti S (2001) A protective role for kidney apolipoprotein E. J Biol Chem 276(52):49142
45. Kim HJ, Cho EH, Yoo JH, Kim PK, Shin JS, Kim MR, Kim CW (2007) Proteome analysis of serum from type 2 diabetics with nephropathy. J Proteome Res 6(2):735-743
46. Liu Y, Cao DJ, Sainz IM, Guo YL, Colman RW (2008) The inhibitory effect of HKa in endothelial cell tube formation is mediated by disrupting the uPA-uPAR complex and inhibiting its signaling and internalization. Am J Physiol Cell Physiol 295(1):C257-C267. doi:10.1152/ajpcell.00569.2007
47. Rocchetti MT, Centra M, Papale M, Bortone G, Palermo C, Centonze D, Ranieri E, Di Paolo S, Gesualdo L (2008) Urine protein profile of IgA nephropathy patients may predict the response to ACE-inhibitor therapy. Proteomics 8(1):206-216. doi:10.1002/pmic.200700492
48. Weinberg MS, Azar P, Trebbin WM, Solomon RJ (1985) The role of urinary kininogen in the regulation of kinin generation. Kidney Int 28(6):975-981
49. Abdullah-Soheimi SS, Lim BK, Hashim OH, Shuib AS (2010) Patients with ovarian carcinoma excrete different altered levels of urine CD59, kininogen-1 and fragments of inter-alpha-trypsin inhibitor heavy chain H4 and albumin. Proteome Sci 8:58. doi: 10.1186/1477-5956-8-58
50. Everaert K, Delanghe J, Vande Wiele C, Hoebeke P, Dierckx RA, Clarysse B, Lameire N, Oosterlinck W (1998) Urinary alpha 1-microglobulin detects uropathy. A prospective study in 483 urological patients. Clinical chemistry and laboratory medicine. CCLM/FESCC 36(5):309-315. doi:10.1515/CCLM.1998.052
51. Pfleiderer S, Zimmerhackl L, Kinne R, Manz F, Schuler G, Brandis M (1993) Renal proximal and distal tubular function is attenuated in diabetes mellitus type 1 as determined by the renal excretion of a 1-microglobulin and Tamm-Horsfall protein. J Mol Med 71(12):972-977
52. Wainai H, Katsukawa F, Takei I, Maruyama H, Kataoka K, Saruta T (1991) Influence of glycemic control and hypertension on urinary microprotein excretion in non-insulin-dependent diabetes mellitus. J Diabetic Complicat 5(2-3):160-161
53. Hassan MI, Waheed A, Yadav S, Singh TP, Ahmad F (2008) Zinc alpha 2-glycoprotein: a multidisciplinary protein. Mol Cancer Res 6(6):892-906. doi:10.1158/1541-7786.MCR-07-2195
54. BingC, Bao Y, Jenkins J, Sanders P,ManieriM, Cinti S, Tisdale MJ, Trayhurn P (2004) Zinc-alpha2-glycoprotein, a lipid mobilizing factor, is expressed in adipocytes and is up-regulated in mice with cancer cachexia. Proc Nat Acad Sci USA 101(8):2500-2505
55. Rolli V, Radosavljevic M, Astier V, Macquin C, Castan-Laurell I, Visentin V, Guigne C, Carpene C, Valet P, Gilfillan S, Bahram S (2007) Lipolysis is altered in MHC class I zinc-alpha(2)-glycoprotein deficient mice. FEBS Lett 581(3):394-400. doi:10.1016/j.febslet.2006.12.047
56. Agrawal V, Shah A, Rice C, Franklin BA, McCullough PA (2009) Impact of treating the metabolic syndrome on chronic kidney disease. Nat Rev Nephrol 5(9):520-528. doi:10.1038/nrneph.2009.114
57. Varghese SA, Powell TB, Budisavljevic MN, Oates JC, Raymond JR, Almeida JS, Arthur JM (2007) Urine biomarkers predict the cause of glomerular disease. J Am Soc Nephrol 18(3):913-922. doi:10.1681/ASN.2006070767
58. Pesic I, Stefanovic V, Muller GA, Muller CA, Cukuranovic R, Jahn O, Bojanic V, Koziolek M, Dihazi H (2011) Identification and validation of six proteins as marker for endemic nephropathy. J Proteomics 74(10):1994-2007. doi:10.1016/j.jprot.2011.05.020
59. Riaz S, Alam SS, Srai SK, Skinner V, Riaz A, Akhtar MW (2010) Proteomic identification of human urinary biomarkers in diabetes mellitus type 2. Diabetes Technol Ther 12(12):979-988. doi: 10.1089/dia.2010.0078
60. Lim SC, Liying DQ, Toy WC, Wong M, Yeoh LY, Tan C, Lau D, Subramaniam T, Sum CF (2011) Adipocytokine zinc alpha(2) glycoprotein (ZAG) as a novel urinary biomarker for normoalbuminuric diabetic nephropathy. Diabet Med. doi:10.1111/j.1464-5491.2011.03564.x
61. Jain S, Rajput A, Kumar Y, Uppuluri N, Arvind AS, Tatu U (2005) Proteomic analysis of urinary protein markers for accurate prediction of diabetic kidney disorder. J Assoc Phys India 53:513-520
62. Ishioka N, Takahashi N, Putnam FW (1986) Amino acid sequence of human plasma alpha 1B-glycoprotein: homology to the immunoglobulin supergene family. Proc Nat Acad Sci USA 83(8):2363-2367
63. Araki T, Gejyo F, Takagaki K, Haupt H, Schwick HG, Burgi W, Marti T, Schaller J, Rickli E, Brossmer R et al (1988) Complete amino acid sequence of human plasma Zn-alpha 2-glycoprotein and its homology to histocompatibility antigens. Proc Natl Acad Sci USA 85(3):679-683
64. Catanese JJ, Kress LF (1992) Isolation from opossum serum of a metalloproteinase inhibitor homologous to human alpha 1B-glycoprotein. Biochemistry 31(2):410-418
65. Kreunin P, Zhao J, Rosser C, Urquidi V, Lubman DM, Goodison S (2007) Bladder cancer associated glycoprotein signatures revealed by urinary proteomic profiling. J Proteome Res 6(7):2631-2639. doi:10.1021/pr0700807
66. Goo YA, Tsai YS, Liu AY, Goodlett DR, Yang CC (2010) Urinary proteomics evaluation in interstitial cystitis/painful bladder syndrome: a pilot study. Int Braz J Urol 36(4):464-478; discussion 478-469, 479
67. Newcomer ME, Ong DE (2000) Plasma retinol binding protein: structure and function of the prototypic lipocalin. Biochimica et Biophysica Acta 1482(1-2):57-64
68. Yang Q, Graham TE, Mody N, Preitner F, Peroni OD, Zabolotny JM, Kotani K, Quadro L, Kahn BB (2005) Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 436(7049):356-362. doi:10.1038/nature03711
69. Graham TE, Yang Q, Bluher M, Hammarstedt A, Ciaraldi TP, Henry RR, Wason CJ, Oberbach A, Jansson PA, Smith U, Kahn BB (2006) Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects.NEngl JMed354(24):2552-2563. doi: 10.1056/NEJMoa054862
70. Kotnik P, Fischer-Posovszky P, Wabitsch M (2011) RBP4: a controversial adipokine. Eur J Endocrinol 165(5):703-711. doi: 10.1530/EJE-11-0431
71. Christou GA, Tselepis AD, Kiortsis DN (2012) The metabolic role of retinol binding protein 4: an update. Horm Metab Res 44(1):6-14. doi:10.1055/s-0031-1295491
72. Watts GF, Powell M, Rowe DJ, Shaw KM (1989) Low-molecular- weight proteinuria in insulin-dependent diabetes mellitus: a study of the urinary excretion of beta 2-microglobulin and retinol- binding protein in alkalinized patients with and without microalbuminuria. Diabetes Res 12(1):31-36
73. Pontuch P, Toserova E, Vozar J, Bulas J, Kratochvilova H (1995) 24-h Ambulatory blood pressure, daytime and nighttime urinary albumin and retinol-binding protein excretion in type I diabetic patients. J Diabetes Complicat 9(4):234-236
74. Galanti LM, Jamart J, Dell'omo J, Donckier J (1996) Comparison of urinary excretion of albumin, alpha 1-microglobulin and retinol- binding protein in diabetic patients. Diabetes Metab 22(5): 324-330
75. Dubrey SW, Beetham R, Miles J, Noble MI, Rowe R, Leslie RD (1997) Increased urinary albumin and retinol-binding protein in type I diabetes. A study of identical twins. Diabetes Care 20(1):84-89
76. Shimizu H, Negishi M, Shimomura Y, Mori M (1992) Changes in urinary retinol binding protein excretion and other indices of renal tubular damage in patients with non-insulin dependent diabetes. Diabetes Res Clin Pract 18(3):207-210
77. Chen CC, Wu JY, Chang CT, Tsai FJ, Wang TY, Liu YM, Tsui HC, Chen RH, Chiou SC (2009) Levels of retinol-binding protein 4 and uric acid in patients with type 2 diabetes mellitus. Metab Clin Exp 58(12):1812-1816. doi:10.1016/j.metabol.2009.06.013
78. Akbay E, Muslu N, Nayir E, Ozhan O, Kiykim A (2010) Serum retinol binding protein 4 level is related with renal functions in type 2 diabetes. J Endocrinol Invest 33(10):725-729. doi:10.3275/7024
79. Li ZZ, Lu XZ, Liu JB, Chen L (2010) Serum retinol-binding protein 4 levels in patients with diabetic retinopathy. J Int Med Res 38(1):95-99
80. Lisowska-Myjak B (2010) Serum and urinary biomarkers of acute kidney injury. Blood Purif 29(4):357-365. doi:10.1159/000309421
81. Varghese SA, Powell TB, Janech MG, Budisavljevic MN, Stanislaus RC, Almeida JS, Arthur JM (2010) Identification of diagnostic urinary biomarkers for acute kidney injury. J Investig Med 58(4):612-620. doi:10.231/JIM. 0b013e3181d473e7
82. Chu CH, Lam HC, Lee JK, Lu CC, Sun CC, Cheng HJ, Wang MC, Chuang MJ (2011) Elevated serum retinol-binding protein 4 concentrations are associated with chronic kidney disease but not with the higher carotid intima-media thickness in type 2 diabetic subjects. Endocr J 58(10):841-847
83. Salem MA, el-Habashy SA, Saeid OM, el-Tawil MM, Tawfik PH (2002) Urinary excretion of n-acetyl-beta-D-glucosaminidase and retinol binding protein as alternative indicators of nephropathy in patients with type 1 diabetes mellitus. Pediatr Diabetes 3(1):37-41. doi:10.1034/j.1399-5448.2002.30107.x
84. Astorri E, Guglielmi C, Bombardieri M, Alessandri C, Buzzetti R, Maggi D, Valesini G, Pitzalis C, Pozzilli P (2010) Circulating Reg1alpha proteins and autoantibodies to Reg1alpha proteins as biomarkers of beta-cell regeneration and damage in type 1 diabetes. Horm Metab Res 42(13):955-960. doi:10.1055/s-0030- 1267206